Catalyst Wire Dossier Catalyst Wire Dossier

CHF6333

· Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHF6333, covering 2017-11-07 to 2017-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects [Phase 1]

See pricing